Literature DB >> 15707993

Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae.

Kazumi Hiraga1, Shogo Yamamoto, Hiroyuki Fukuda, Nobuyuki Hamanaka, Kohei Oda.   

Abstract

Pdr5p is one of the major multidrug efflux pumps whose overexpression confers multidrug resistance (MDR) in Saccharomyces cerevisiae. By using our original assay system, a fungal strain producing inhibitors for Pdr5p was obtained and classified as Fusarium sp. Y-53. The purified inhibitors were identified as ionophore antibiotics, enniatin B, B1, and D, respectively. A non-toxic concentration of each enniatin (5 microg/ml, approximately 7.8 microM) strongly inhibited a Pdr5p-mediated efflux of cycloheximide or cerulenin in Pdr5p-overexpressing cells. The enniatins accumulated a fluorescent dye rhodamine 123, a substrate of Pdr5p, into yeast cells. The mode of Pdr5p inhibition of enniatin was competitive against FK506, and its inhibitory activity was more potent with less toxicity than that of FK506. The enniatins showed similar inhibitory profile as FK506 against S1360 mutants (S1360A and S1360F) of Pdr5p. The enniatins did not inhibit the function of Snq2p, a homologue of Pdr5p. Thus, it was found that enniatins are potent and specific inhibitors for Pdr5p, with less toxicities than that of FK506.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707993     DOI: 10.1016/j.bbrc.2005.01.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Targeting efflux pumps to overcome antifungal drug resistance.

Authors:  Ann R Holmes; Tony S Cardno; J Jacob Strouse; Irena Ivnitski-Steele; Mikhail V Keniya; Kurt Lackovic; Brian C Monk; Larry A Sklar; Richard D Cannon
Journal:  Future Med Chem       Date:  2016-07-27       Impact factor: 3.808

Review 2.  Revisiting the enniatins: a review of their isolation, biosynthesis, structure determination and biological activities.

Authors:  Arlene A Sy-Cordero; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Antibiot (Tokyo)       Date:  2012-09-19       Impact factor: 2.649

3.  The emerging Fusarium toxin enniatin B: in-vitro studies on its genotoxic potential and cytotoxicity in V79 cells in relation to other mycotoxins.

Authors:  Wolfram Föllmann; Claudia Behm; Gisela H Degen
Journal:  Mycotoxin Res       Date:  2008-12-17       Impact factor: 3.833

4.  Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae.

Authors:  Erwin Lamping; Brian C Monk; Kyoko Niimi; Ann R Holmes; Sarah Tsao; Koichi Tanabe; Masakazu Niimi; Yoshimasa Uehara; Richard D Cannon
Journal:  Eukaryot Cell       Date:  2007-05-18

5.  FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops.

Authors:  Koichi Tanabe; Michele Bonus; Susumu Tomiyama; Kunji Miyoshi; Minoru Nagi; Kyoko Niimi; Ariya Chindamporn; Holger Gohlke; Lutz Schmitt; Richard D Cannon; Masakazu Niimi; Erwin Lamping
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

6.  ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.

Authors:  Ann R Holmes; Ya-Hsun Lin; Kyoko Niimi; Erwin Lamping; Mikhail Keniya; Masakazu Niimi; Koichi Tanabe; Brian C Monk; Richard D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

7.  Detection of inhibitors of Candida albicans Cdr transporters using a diS-C3(3) fluorescence.

Authors:  Joanna Szczepaniak; Marcin Łukaszewicz; Anna Krasowska
Journal:  Front Microbiol       Date:  2015-03-09       Impact factor: 5.640

8.  Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae.

Authors:  Leandro Figueira Reis de Sá; Fabiano Travanca Toledo; Bruno Artur de Sousa; Augusto César Gonçalves; Ana Claudia Tessis; Edison P Wendler; João V Comasseto; Alcindo A Dos Santos; Antonio Ferreira-Pereira
Journal:  BMC Microbiol       Date:  2014-07-26       Impact factor: 3.605

9.  Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

Authors:  Christina Kourtesi; Anthony R Ball; Ying-Ying Huang; Sanjay M Jachak; D Mariano A Vera; Proma Khondkar; Simon Gibbons; Michael R Hamblin; George P Tegos
Journal:  Open Microbiol J       Date:  2013-03-22

Review 10.  Risks of Mycotoxins from Mycoinsecticides to Humans.

Authors:  Qiongbo Hu; Fuxia Li; Yuping Zhang
Journal:  Biomed Res Int       Date:  2016-04-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.